AARD
AARD
NASDAQ · Pharmaceuticals

Aardvark Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$1.17
+0.06 (+5.41%)
As of Nov 7, 10:33 PM ET ·
Analyst Consensus
Buy
17
Analysts
High
Coverage
Buy 10 59%
Hold 5 29%
Sell 2 12%
Price Target
Analyst Price Target +2,142.7% upside
Low Target $21.03
Average Target $26.24
High Target $41.18
Current Price $1.17
Current
$1.17
Target
$26.24
$21.03 $26.24 avg $41.18
Scenario Analysis
Bear Case
$21.03
1,697.4%
Low target
Base Case
$26.24
+2,142.7%
Avg target
Bull Case
$41.18
+3,419.7%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$16.60
-93.0% from high
52-Week Low
$0.93
+25.8% from low
Target vs 52W High
$26.24
+58.1% vs high
Next Earnings Report
Nov 12, 2026
3d
until earnings
EPS Est: $-0.74
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 37 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
 Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
 Buy 30 70% $299.55 +8.4%
MRK
Merck & Co. Inc.
 Buy 35 71% $159.27 +8.5%
PFE
Pfizer Inc.
 Hold 34 38% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
 Hold 34 41% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
 Hold 22 41% $209.87 +164.3%